Neuronetics, Inc.

NasdaqGM:STIM Voorraadrapport

Marktkapitalisatie: US$31.2m

Neuronetics Beheer

Beheer criteriumcontroles 1/4

De CEO Neuronetics is Keith Sullivan, benoemd in Jul2020, heeft een ambtstermijn van 4.33 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 2.99M, bestaande uit 23.4% salaris en 76.6% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 2.44% van de aandelen van het bedrijf, ter waarde $ 761.88K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 1.8 jaar en 4.3 jaar.

Belangrijke informatie

Keith Sullivan

Algemeen directeur

US$3.0m

Totale compensatie

Percentage CEO-salaris23.4%
Dienstverband CEO4.3yrs
Eigendom CEO2.4%
Management gemiddelde ambtstermijn1.8yrs
Gemiddelde ambtstermijn bestuur4.3yrs

Recente managementupdates

Here's Why Shareholders May Want To Be Cautious With Increasing Neuronetics, Inc.'s (NASDAQ:STIM) CEO Pay Packet

May 24
Here's Why Shareholders May Want To Be Cautious With Increasing Neuronetics, Inc.'s (NASDAQ:STIM) CEO Pay Packet

Recent updates

Investors Give Neuronetics, Inc. (NASDAQ:STIM) Shares A 60% Hiding

Aug 13
Investors Give Neuronetics, Inc. (NASDAQ:STIM) Shares A 60% Hiding

Here's Why Shareholders May Want To Be Cautious With Increasing Neuronetics, Inc.'s (NASDAQ:STIM) CEO Pay Packet

May 24
Here's Why Shareholders May Want To Be Cautious With Increasing Neuronetics, Inc.'s (NASDAQ:STIM) CEO Pay Packet

The Neuronetics, Inc. (NASDAQ:STIM) First-Quarter Results Are Out And Analysts Have Published New Forecasts

May 09
The Neuronetics, Inc. (NASDAQ:STIM) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Neuronetics: Reality Set In

May 09

Market Cool On Neuronetics, Inc.'s (NASDAQ:STIM) Revenues Pushing Shares 36% Lower

May 08
Market Cool On Neuronetics, Inc.'s (NASDAQ:STIM) Revenues Pushing Shares 36% Lower

Neuronetics (NASDAQ:STIM) Has Debt But No Earnings; Should You Worry?

May 01
Neuronetics (NASDAQ:STIM) Has Debt But No Earnings; Should You Worry?

Even With A 26% Surge, Cautious Investors Are Not Rewarding Neuronetics, Inc.'s (NASDAQ:STIM) Performance Completely

Mar 17
Even With A 26% Surge, Cautious Investors Are Not Rewarding Neuronetics, Inc.'s (NASDAQ:STIM) Performance Completely

Neuronetics: Modest Improvements Are Not Enough

Jan 30

Neuronetics, Inc. (NASDAQ:STIM) Soars 61% But It's A Story Of Risk Vs Reward

Dec 19
Neuronetics, Inc. (NASDAQ:STIM) Soars 61% But It's A Story Of Risk Vs Reward

Neuronetics, Inc.'s (NASDAQ:STIM) Shares Not Telling The Full Story

Jun 21
Neuronetics, Inc.'s (NASDAQ:STIM) Shares Not Telling The Full Story

Does Neuronetics (NASDAQ:STIM) Have A Healthy Balance Sheet?

May 10
Does Neuronetics (NASDAQ:STIM) Have A Healthy Balance Sheet?

Neuronetics: Growth To Capture, But Fairly Priced

Sep 06

Is Neuronetics (NASDAQ:STIM) Using Debt Sensibly?

Sep 06
Is Neuronetics (NASDAQ:STIM) Using Debt Sensibly?

Neuronetics gets FDA nod for its D-Tect accessory product for use to treat depression

Aug 29

Neuronetics GAAP EPS of -$0.39 beats by $0.02, revenue of $16.3M beats by $0.84M , revises FY guidance

Aug 02

Neuronetics stock soars 30% as FDA clears NeuroStar system for anxious depression

Jul 19

Is Neuronetics (NASDAQ:STIM) A Risky Investment?

Jun 08
Is Neuronetics (NASDAQ:STIM) A Risky Investment?

Analyse CEO-vergoeding

Hoe is Keith Sullivan's beloning veranderd ten opzichte van Neuronetics's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

-US$32m

Mar 31 2024n/an/a

-US$28m

Dec 31 2023US$3mUS$700k

-US$30m

Sep 30 2023n/an/a

-US$33m

Jun 30 2023n/an/a

-US$31m

Mar 31 2023n/an/a

-US$37m

Dec 31 2022US$2mUS$676k

-US$37m

Sep 30 2022n/an/a

-US$37m

Jun 30 2022n/an/a

-US$37m

Mar 31 2022n/an/a

-US$34m

Dec 31 2021US$3mUS$650k

-US$31m

Sep 30 2021n/an/a

-US$27m

Jun 30 2021n/an/a

-US$22m

Mar 31 2021n/an/a

-US$23m

Dec 31 2020US$4mUS$280k

-US$27m

Compensatie versus markt: De totale vergoeding ($USD 2.99M ) Keith } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 655.65K ).

Compensatie versus inkomsten: De vergoeding van Keith is gestegen terwijl het bedrijf verliesgevend is.

CEO

Keith Sullivan (66 yo)

4.3yrs

Tenure

US$2,990,985

Compensatie

Mr. Keith J. Sullivan has been President, Chief Executive Officer and Director of Neuronetics, Inc. since July 14, 2020. Mr. Sullivan has been a Director of Venus Concept Inc. (formerly known as Restoratio...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Keith Sullivan
President4.3yrsUS$2.99m2.44%
$ 761.9k
Stephen Furlong
Executive VP5.3yrsUS$1.36m0.85%
$ 264.6k
W. Macan
Executive VP4.8yrsUS$1.16m0.60%
$ 187.7k
Rusty Page
Senior VP of Operations & Quality1.8yrsgeen gegevensgeen gegevens
Lisa Metzner-Rosas
Senior VP & Chief Marketing Officer1.5yrsgeen gegevensgeen gegevens
Sara Grubbs
Senior VP & Chief Revenue Officer1.8yrsgeen gegevensgeen gegevens
Rick Grubbs
Senior Vice President of National Accounts1.8yrsgeen gegevensgeen gegevens
Cory Anderson
Senior Vice President of R&D and Clinical1.8yrsgeen gegevensgeen gegevens

1.8yrs

Gemiddelde duur

60yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van STIM wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.8 jaar), wat duidt op een nieuw team.

Bestuursleden

NaamPositieTenureCompensatieEigendom
Keith Sullivan
President4.3yrsUS$2.99m2.44%
$ 761.9k
Glenn Muir
Independent Director7.3yrsUS$182.50k0.67%
$ 209.6k
Sheryl Conley
Independent Director5.1yrsUS$175.00k0.26%
$ 80.9k
Robert Cascella
Independent Chairman of the Board3.6yrsUS$245.00k1.06%
$ 331.5k
Megan Rosengarten
Independent Director3.3yrsUS$162.50k0.28%
$ 88.5k

4.3yrs

Gemiddelde duur

65yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van STIM wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.3 jaar).